SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Mead, J. C.
Right arrow Articles by Whiting, P.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mead, J. C.
Right arrow Articles by Whiting, P.H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The Relationship Between Total Kidney Cyclosporin A Concentrations, Trough Drug Levels and Renal Function in the Rat Following Withdrawal of Treatment

John C. Mead

Department of Medicine and Therapeutics, University of Aberdeen, Medical Buildings, Foresterhill, Aberdeen AB9 2ZD, UK, Department of Clinical Biochemistry, University of Aberdeen, Medical Buildings, Foresterhill, Aberdeen AB9 2ZD, UK

P.A.J. Brown

Department of Pathology, University of Aberdeen, Medical Buildings, Foresterhill, Aberdeen AB9 2ZD, UK

P.H. Whiting

Department of Clinical Biochemistry, University of Aberdeen, Medical Buildings, Foresterhill, Aberdeen AB9 2ZD, UK

Groups of 6 male rats received cyclosporin A (CsA: 20 mg kg-1 day-1) by gavage for either 4, 7, 10 or 14 days and were sacrificed 24 hours later. CsA nephrotoxicity was characterised functionally by decreased creatinine clearance rates and increased enzymuria. A significant correlation (r2=0.980; P<0.01 ) was observed between the CsA concentration in renal tissue (4.88± 2.16, 13.54± 3.68, 25.71±6.59 and 36.64± 6.797 µg g-1 kidney wet weight, [mean±SD] on days 4, 7, 10 and 14 respectively) and trough whole blood (TWB) CsA concentrations (0.86± 0.18, 1.82± 0.59, 3.35± 0.52 and 3.70± 1.12 µg ml-1, respectively) was observed. Furthermore, an apparent relationship between both renal tissue and TWB CsA concentration, the degree of renal microcalcification (MC) at the cortico-medullary junction and magnitude of the renal dysfunction was observed. In a second experiment, treatment was withdrawn after 14 days at 20 mg kg-1 day-1. Following withdrawal of treatment for 1, 4, 7, 10 or 14 days, renal tissue and whole blood CsA concentrations fell progressively from 32.23± 11.23 and 3.01±0.96 (µg g-1 wet weight and µg ml-1, respectively) to 25.66±9.77 and 2.12± 0.66, 10.42± 0.65 and 0.78± 0.23, 4.35± 1.2 and 0.51± 0.16, 3.98± 3.76 and 0.27± 0.03, and 2.58± 1.56 and Not Detected. However, the severity of MC was maintained over this period and while values for urinary flow rate, glycosuria and NAG were similar to pretreatment values by day 14, those for creatinine clearance rate were not (325± 43 v 421 ± 91 ml h-1 kg-1 body weight [mean±SD], P<0.01). These results suggest that MC, an early feature of chronic CsA toxicity is both irreversible and not related to either TWB or tissue CsA concentrations.

Human & Experimental Toxicology, Vol. 13, No. 7, 506-511 (1994)
DOI: 10.1177/096032719401300710


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement